Traxion Sab De Cv Ord Shs GRPOF

The fearmongering continues.

[Sweeetydi]

There is so much misinformation circulating on this board.

To reiterate my post from yesterday.  The delay in shareholders being informed had to do with TBP receiving all testing information, relaying this onto patients and then ultimately shareholders.  The last batch of tests were received 1 Feb 2019.

Phase 3 does not need to be repeated.  This implies that they have sufficient data and that patients did not receive contaminated drugs. 

Tetras trials are suspended so that TBP can develope a quality initiative that allows for safe drying and storage of their drug.  Patient safety is their priority, hence why they immediately went to HC with their findings. 

TBP are now working with HC to create a gold standard for storing and drying cannabis.  This incident may also have huge ramifications for rec/medical markets and what they’re going to need to test for.

If anything, once TBP are able to say their drug is 100% contaminant free they will become the prescription of choice.  Trust is a big thing in medicine and I feel physicians will likely not feel comfortable recommending raw cannabis to patients not knowing if it contains toxins.

To the person panicking saying “what if they can’t fix this”. Well, that’s a worst case scenario. In that event, absolutely no raw cannabis will ever be able to be validated and considered pharma grade.  Given Guys background and the scientists working for Tetra, I feel confident this is fixable. 

My question is wondering is the six month delay starting from December or February?  I’d imagine they began working on this immediately.

IF this problem wasn’t fixable, it’s important to note TBP has the entire chemical profile for the smoke and vapor for ppp001.  They have also submitted patent applications to “heavily” protect their discovery.  Enters biosynthesis. 

Hope this helps clear the air for some people getting lost in the sea of misinformation.